| Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Y Nagata, R Zhao, H Awada, CM Kerr, I Mirzaev, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 136 (20), 2249-2262, 2020 | 67 | 2020 |
| Consequences of mutant TET2 on clonality and subclonal hierarchy CM Hirsch, A Nazha, K Kneen, ME Abazeed, M Meggendorfer, ... Leukemia 32 (8), 1751-1761, 2018 | 64 | 2018 |
| Vacuolization of hematopoietic precursors: an enigma with multiple etiologies C Gurnari, S Pagliuca, L Durkin, L Terkawi, H Awada, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 137 (26), 3685-3689, 2021 | 62 | 2021 |
| Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes Y Nagata, H Makishima, CM Kerr, BP Przychodzen, M Aly, A Goyal, ... Nature communications 10 (1), 5386, 2019 | 58 | 2019 |
| Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes Y Nagata, S Narumi, Y Guan, BP Przychodzen, CM Hirsch, H Makishima, ... Blood, The Journal of the American Society of Hematology 132 (21), 2309-2313, 2018 | 54 | 2018 |
| Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia H Awada, A Durmaz, C Gurnari, A Kishtagari, M Meggendorfer, CM Kerr, ... Blood, The Journal of the American Society of Hematology 138 (19), 1885-1895, 2021 | 44 | 2021 |
| Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia H Awada, Y Nagata, A Goyal, MF Asad, B Patel, CM Hirsch, ... Blood advances 3 (3), 339-349, 2019 | 40 | 2019 |
| Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome J Durrani, H Awada, A Kishtagari, V Visconte, C Kerr, V Adema, Y Nagata, ... Leukemia 34 (3), 957-962, 2020 | 35 | 2020 |
| The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders S Pagliuca, C Gurnari, H Awada, A Kishtagari, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 138 (26), 2781-2798, 2021 | 30 | 2021 |
| Genomics of therapy-related myeloid neoplasms T Kuzmanovic, BJ Patel, SR Sanikommu, Y Nagata, H Awada, CM Kerr, ... Haematologica 105 (3), e98, 2020 | 29 | 2020 |
| Essential thrombocythemia and acquired von willebrand syndrome: the shadowlands between thrombosis and bleeding H Awada, MT Voso, P Guglielmelli, C Gurnari Cancers 12 (7), 1746, 2020 | 28 | 2020 |
| Current status of intralesional agents in treatment of malignant melanoma M Zawit, U Swami, H Awada, J Arnouk, M Milhem, Y Zakharia Annals of translational medicine 9 (12), 2021 | 25 | 2021 |
| The genomics of myelodysplastic syndromes: origins of disease evolution, biological pathways, and prognostic implications H Awada, B Thapa, V Visconte Cells 9 (11), 2512, 2020 | 23 | 2020 |
| BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes N Abuhadra, S Mukherjee, K Al-Issa, V Adema, CM Hirsch, A Advani, ... Leukemia & lymphoma 60 (6), 1587-1590, 2019 | 22 | 2019 |
| A comprehensive review of the genomics of multiple myeloma: Evolutionary trajectories, gene expression profiling, and emerging therapeutics H Awada, B Thapa, H Awada, J Dong, C Gurnari, P Hari, B Dhakal Cells 10 (8), 1961, 2021 | 20 | 2021 |
| Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignancies H Awada, RZ Mahfouz, A Kishtagari, T Kuzmanovic, J Durrani, CM Kerr, ... British Journal of Haematology 188 (6), 924-929, 2020 | 16 | 2020 |
| Novel invariant features of Good syndrome C Gurnari, J Durrani, S Pagliuca, A Kishtagari, H Awada, CM Kerr, ... Leukemia 35 (6), 1792-1796, 2021 | 13 | 2021 |
| A personalized prediction model to risk stratify patients with acute myeloid leukemia (AML) using artificial intelligence J Shreve, M Meggendorfer, H Awada, S Mukherjee, W Walter, S Hutter, ... Blood 134, 2091, 2019 | 13 | 2019 |
| Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes H Awada, C Gurnari, A Durmaz, H Awada, S Pagliuca, V Visconte International Journal of Molecular Sciences 23 (5), 2802, 2022 | 12 | 2022 |
| TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes C Gurnari, S Pagliuca, Y Guan, V Adema, CE Hershberger, Y Ni, ... Blood advances 6 (1), 100-107, 2022 | 12 | 2022 |
